| NCT03108326 | Ced Service GmbH | Crohn Disease | 2017-04-15 | |
| NCT00730717 | Wright State University|Stanford University|Wake Forest University Health Sciences | Pyoderma Gangrenosum | 2009-05 | PHASE2 |
| NCT02744755 | Sandoz|Hexal AG | Rheumatoid Arthritis | 2016-03-31 | PHASE3 |
| NCT01870986 | Pfizer | Healthy | 2013-05 | PHASE1 |
| NCT02871635 | Boehringer Ingelheim | Crohn Disease | 2016-09-28 | PHASE3 |
| NCT01497717 | Rambam Health Care Campus|Abbott | Arthritis; Behcet | 2013-07 | PHASE3 |
| NCT00193648 | Northwell Health|University of North Carolina|The Cleveland Clinic | Focal Glomerulosclerosis | 2005-07 | PHASE1 |
| NCT06729463 | South Valley University | Psoriasis|Psoriatic Arthritis | 2024-12-01 | NA |
| NCT01704599 | Wayne State University|Abbott | Psoriasis | 2009-01 | PHASE1|PHASE2 |
| NCT05683626 | Sohag University | Uveitis | 2022-12-15 | |
| NCT05637515 | Biocon Biologics Inc.|Mylan Inc.|MEDA Pharma GmbH & Co. KG|IQVIA Pvt. Ltd | Moderate Chronic Plaque Psoriasis|Severe Chronic Plaque Psoriasis | 2022-11-21 | PHASE3 |
| NCT05372939 | Applied Molecular Transport | Ulcerative Colitis | 2021-02-05 | PHASE2 |
| NCT02167139 | Samsung Bioepis Co., Ltd. | Rheumatoid Arthritis | 2014-05 | PHASE3 |
| NCT02451748 | University of Illinois at Chicago|UCB Pharma | Rheumatoid Arthritis | 2015-08 | PHASE4 |
| NCT00761514 | Abbott | Rheumatoid Arthritis | 2006-11 | PHASE4 |
| NCT03789292 | Celltrion | Rheumatoid Arthritis | 2018-11-26 | PHASE3 |
| NCT05510063 | Samsung Bioepis Co., Ltd.|Organon and Co | Plaque Psoriasis | 2022-08-04 | PHASE4 |
| NCT01872546 | Poitiers University Hospital | Chronic Plaque Psoriasis | | PHASE2 |
| NCT04135508 | Bio-Thera Solutions | Ankylosing Spondylitis | 2016-12-13 | PHASE3 |
| NCT02016105 | Sandoz|Hexal AG | Plaque Type Psoriasis | 2013-12 | PHASE3 |
| NCT00513370 | Abbott | Psoriasis | 2007-09 | PHASE3 |
| NCT01078610 | Abbott | Psoriatic Arthritis | | |
| NCT00932113 | Tufts Medical Center | Psoriasis | 2009-06 | PHASE4 |
| NCT03014947 | Fresenius Kabi SwissBioSim GmbH | Healthy Subjects | 2014-05 | PHASE1 |
| NCT00696059 | Hvidovre University Hospital|Abbott | Rheumatoid Arthritis|Arthritis|Joint Diseases | 2004-08 | PHASE4 |
| NCT00478660 | Abbott | Ankylosing Spondylitis | 2006-02 | PHASE3 |
| NCT04131322 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Crohn Disease|Ulcerative Colitis | 2019-10-10 | PHASE4 |
| NCT03651518 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Inflammatory Disease|Autoimmune Diseases | 2020-10-20 | PHASE2 |
| NCT05108259 | Prestige Biopharma Limited | Healthy Volunteers | 2022-03-30 | PHASE1 |
| NCT01553058 | University of Pennsylvania | Psoriasis|Cardiovascular Disease | 2012-07 | PHASE4 |
| NCT00512863 | Abbott | Asthma | 2007-08 | PHASE2 |
| NCT02395055 | Biocad | Healthy | 2015-06 | PHASE1 |
| NCT02206867 | LG Life Sciences | Healthy Subjects | 2014-08 | PHASE1 |
| NCT07181694 | Biocad | Healthy Adult Male | 2025-03-12 | PHASE1 |
| NCT02581345 | Momenta Pharmaceuticals, Inc. | Chronic Plaque Psoriasis|Psoriasis | 2015-09 | PHASE3 |
| NCT07128472 | South Valley University | Psoriasis | 2025-08-01 | NA |
| NCT03970824 | Celltrion | Healthy | 2019-05-31 | PHASE1 |
| NCT06005532 | Mabscale, LLC | Plaque Psoriasis | 2023-10-02 | PHASE3 |
| NCT00775437 | AbbVie (prior sponsor, Abbott) | Juvenile Idiopathic Arthritis | 2009-03 | PHASE3 |
| NCT07398651 | Tanta University | Psoriatic Arthritis|Ultrasound Assessment|TNF | 2026-12-30 | NA |
| NCT04132388 | Wake Forest University Health Sciences | Hidradenitis Suppurativa | 2020-08-20 | PHASE4 |
| NCT04251741 | Reade Rheumatology Research Institute|ZonMw: The Netherlands Organisation for Health Research and Development|Sint Maartenskliniek | Rheumatoid Arthritis | 2020-07-31 | PHASE4 |
| NCT05874505 | Assistance Publique - H?pitaux de Paris | Behcet´s Uveitis | 2023-07 | PHASE2 |
| NCT03104400 | AbbVie | Psoriatic Arthritis | 2017-04-27 | PHASE3 |
| NCT04088409 | Eli Lilly and Company | Uveitis | 2019-10-16 | PHASE3 |
| NCT00690911 | Wake Forest University | Sarcoidosis | | PHASE2 |
| NCT00647920 | Abbott | Rheumatoid Arthritis | 2003-07 | PHASE3 |
| NCT03828019 | JHSPH Center for Clinical Trials | Uveitis | 2019-09-16 | PHASE3 |
| NCT06742606 | Ain Shams University | Effect of Drug | 2025-01-15 | EARLY_PHASE1 |
| NCT02904902 | AbbVie | Hidradenitis Suppurativa | 2016-09-06 | PHASE3 |
| NCT02994836 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Crohn´s Disease|Inflammatory Bowel Disease|Ulcerative Colitis | 2017-04-21 | PHASE4 |
| NCT01870284 | Eli Lilly and Company | Spondylitis, Ankylosing | 2014-07 | PHASE3 |
| NCT05706038 | IRCCS San Raffaele | Inflammatory Bowel Diseases|Rheumatic Disorder | 2022-04-27 | |
| NCT00235885 | Abbott | Psoriatic Arthritis | 2005-07 | PHASE3 |
| NCT00233571 | Abbott | Rheumatoid Arthritis | 2000-06 | PHASE3 |
| NCT07151937 | Almirall, S.A. | Hidradenitis Suppurativa | 2025-09 | PHASE2 |
| NCT02065622 | AbbVie | Ulcerative Colitis (UC) | 2014-03-27 | PHASE3 |
| NCT02065570 | AbbVie | Crohn´s Disease | 2014-05-01 | PHASE3 |
| NCT02634541 | University of Helsinki|AbbVie | Ankylosing Spondyloarthritis | 2016-01 | PHASE4 |
| NCT00311246 | University of Chicago|Abbott | Sarcoidosis | 2006-04 | PHASE2 |
| NCT02516774 | Gustave Roussy, Cancer Campus, Grand Paris | Anaplastic Thyroid Cancers | 2014-12 | PHASE1 |
| NCT01148225 | AbbVie | Uveitis | 2010-11-23 | PHASE3 |
| NCT06849908 | Peking Union Medical College Hospital | Behcet Syndrome, Intestinal Type | 2024-11-08 | PHASE2 |
| NCT05151848 | Chinese SLE Treatment And Research Group | Takayasu Arteritis | 2022-01-05 | PHASE4 |
| NCT04115748 | Gilead Sciences|Galapagos NV | Psoriatic Arthritis | 2019-12-03 | PHASE3 |
| NCT01706692 | Swiss Dermatology Network for Targeted Therapies | Psoriasis | 2011-02 | |
| NCT00195663 | AbbVie (prior sponsor, Abbott) | Early Rheumatoid Arthritis | 2000-12 | PHASE3 |
| NCT00927069 | Innovaderm Research Inc.|Abbott | Plaque Psoriasis | 2007-03 | PHASE3 |
| NCT07564505 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn´s Disease | 2026-05 | PHASE4 |
| NCT02187055 | Pfizer | Rhematoid Arthritis | 2014-08 | PHASE4 |
| NCT05313620 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Ulcerative Colitis|Thromboembolism | 2022-04-01 | PHASE4 |
| NCT05322473 | MoonLake Immunotherapeutics AG | Hidradenitis Suppurativa | 2022-04-25 | PHASE2 |
| NCT00409617 | Abbott | Crohn´s Disease | 2006-12 | PHASE3 |
| NCT01893996 | Jonathan Graf|American College of Rheumatology Research and Education Foundation|AbbVie | Rheumatoid Arthritis|Cardiovascular Disease | 2013-07 | PHASE4 |
| NCT00077779 | Abbott | Crohn´s Disease | 2003-07 | PHASE3 |
| NCT01670240 | Odense University Hospital|University of Southern Denmark|Hvidovre University Hospital|Aarhus University Hospital|AbbVie | Ulcerative Colitis|Pouchitis | 2012-08 | PHASE3 |
| NCT02016482 | AbbVie | Nail Psoriasis|Plaque Psoriasis | 2014-01 | PHASE3 |
| NCT02471118 | CARE ARTHRITIS LTD.|AbbVie | Osteoarthritis, Knee | 2015-03 | PHASE2 |
| NCT00234897 | Abbott | Rheumatoid Arthritis | 2004-08 | PHASE4 |
| NCT02750800 | AbbVie | Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Psoriasis|Crohn´s Disease|Ulcerative Colitis | 2016-04-07 | |
| NCT03306446 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | CD | 2015-03-17 | PHASE4 |
| NCT06062875 | Endeavor Health|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Benign Prostatic Hyperplasia (BPH) | 2024-01-24 | PHASE2 |
| NCT02489227 | Coherus Oncology, Inc. | Plaque Psoriasis | 2015-08 | PHASE3 |
| NCT03110094 | Rennes University Hospital | Rheumatoid Arthritis | 2017-03-13 | NA |
| NCT06440629 | Diakonhjemmet Hospital|Oslo University Hospital|Karolinska University Hospital|Queen Mary University of London|Medical University of Vienna|Alesund Hospital|St. Olavs Hospital|Helse Stavanger HF|Drammen sykehus|University Hospital of North Norway|F?rde Hospital Trust|Hospital of Southern Norway Trust|Haukeland University Hospital|Ostfold Hospital Trust|Lillehammer Hospital for Rheumatic Diseases|Vestre Viken Hospital Trust|Haugesund Rheumatism Hospital|Betanien Hospital|Helgeland Hospital Trust|Nordlandssykehuset HF|Carol Davila University of Medicine and Pharmacy|Humanitas Research Hospital IRCCS, Rozzano-Milan|Sahlgrenska University Hospital | Rheumatoid Arthritis | 2024-08-20 | PHASE4 |
| NCT01609205 | Hamed Rezaei|Abbott | Rheumatoid Arthritis | 2012-10 | PHASE4 |
| NCT02256462 | Schneider Children´s Medical Center, Israel | Crohn´s Disease | 2015-05-01 | PHASE4 |
| NCT06033469 | IRCCS Burlo Garofolo | Inflammatory Bowel Diseases | 2018-03-15 | |
| NCT02539849 | Hospital Universitari Vall d´Hebron Research Institute|AbbVie | Crohn Disease | 2014-12 | NA |
| NCT02565810 | Samsung Bioepis Co., Ltd. | Rheumatoid Arthritis | 2015-09 | PHASE2 |
| NCT00517296 | Vanderbilt University Medical Center | Crohn Disease|Rectal Fistula | 2008-01 | PHASE4 |
| NCT04222920 | Reade Rheumatology Research Institute|ZonMw: The Netherlands Organisation for Health Research and Development|Sint Maartenskliniek | Rheumatoid Arthritis | 2020-03-01 | PHASE4 |
| NCT00234234 | University Hospital, Rouen | Rheumatoid Arthritis | 2006-01 | PHASE4 |
| NCT05155592 | Dan Liang | Uveitis|Adalimumab | 2021-01-01 | PHASE2 |
| NCT05015335 | Peking Union Medical College Hospital | Uveitis, Anterior|Adalimumab | 2021-08-19 | PHASE4 |
| NCT01793519 | Georgetown University|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|University of Maryland, Baltimore|Washington D.C. Veterans Affairs Medical Center|Medstar Health Research Institute|Patient-Centered Outcomes Research Institute|Arthritis and Pain Associates of PG County|Arthritis & Rheumatism Associates, P.C.|Rheumatology Associates of Baltimore, L.L.C.|The Arthritis Clinic of Northern Virginia, P.C.|Arthritis and Rheumatic Disease Associates, P.C. | Rheumatoid Arthritis | 2013-01 | PHASE4 |
| NCT02912247 | Innovent Biologics (Suzhou) Co. Ltd. | Healthy | 2016-10-27 | PHASE1 |
| NCT01505491 | Boehringer Ingelheim | Healthy | 2011-12-01 | PHASE1 |
| NCT01674413 | Peter Higgins|AbbVie | Crohn´s Disease | 2013-10 | PHASE3 |
| NCT02163759 | Hoffmann-La Roche | Ulcerative Colitis | 2014-11-04 | PHASE3 |
| NCT06016517 | Tufts Medical Center | Arthritis, Rheumatoid | 2026-05-01 | |
| NCT00055497 | Abbott | Crohn´s Disease | 2002-08 | PHASE3 |
| NCT00409682 | Abbott | Crohn´s Disease | 2007-04 | PHASE3 |
| NCT03823391 | AbbVie | Rheumatoid Arthritis (RA) | 2019-03-27 | PHASE2 |
| NCT07491913 | Marmara University | Takayasu Arteritis | 2025-06-15 | NA |
| NCT01166282 | AbbVie (prior sponsor, Abbott) | Enthesitis Related Arthritis (ERA) | 2010-09 | PHASE3 |
| NCT00647270 | Abbott | Rheumatoid Arthritis | 2007-12 | PHASE3 |
| NCT01812954 | Jochen Schmitt.|Merck Sharp & Dohme LLC | Psoriasis | 2013-03 | |
| NCT02878083 | Nantes University Hospital|Takeda|Mauna Kea Technologies|Institut National de la Santé Et de la Recherche Médicale, France | ULCERATIVE COLITIS | 2017-01-11 | NA |
| NCT00566722 | Abbott | Psoriasis | 2008-01 | PHASE3 |
| NCT03739853 | University of Oxford | Psoriatic Arthritis | 2019-05-14 | PHASE4 |
| NCT01382160 | University Hospital, Tours | Rheumatoid Arthritis | 2011-01 | PHASE4 |
| NCT02889796 | Gilead Sciences|Galapagos NV | Rheumatoid Arthritis | 2016-08-30 | PHASE3 |
| NCT02450513 | Universitaire Ziekenhuizen KU Leuven | Crohn´s Disease | 2012-03 | |
| NCT00480272 | Fondazione IRCCS Policlinico San Matteo di Pavia | Rheumatoid Arthritis | 2007-05 | PHASE4 |
| NCT04655807 | Janssen Research & Development, LLC | Crohn Disease | 2021-03-03 | PHASE2 |
| NCT06390436 | Centre Hospitalier Universitaire de Saint Etienne|Direction Générale de l´Offre de Soins | Uveitis|Chronic Disease | 2025-06 | PHASE4 |
| NCT00940862 | Innovaderm Research Inc.|Abbott|Montreal Heart Institute | Psoriasis|Vascular Inflammation|Coronary Atherosclerosis | 2009-07 | PHASE4 |
| NCT02349451 | AbbVie | Psoriatic Arthritis | 2015-04-28 | PHASE2 |
| NCT04882683 | Shandong Qilu Stem Cells Engineering Co., Ltd. | Ulcerative Colitis | 2021-06-01 | NA |
| NCT03248531 | UCB Biopharma SRL | Hidradenitis Suppurativa | 2017-09-22 | PHASE2 |
| NCT02586831 | Camillo Ricordi and Jay Skyler|Diabetes Research Institute Foundation | Diabetes Mellitus, Type 1|Hypoglycemia|Autoimmune Diseases|Diabetes Mellitus | 2024-06-01 | PHASE1|PHASE2 |
| NCT02497469 | Takeda | Colitis, Ulcerative | 2015-06-29 | PHASE3 |
| NCT00686439 | University of Alberta | Osteoarthritis | 2008-06 | PHASE1|PHASE2 |
| NCT02629159 | AbbVie | Rheumatoid Arthritis | 2015-12-01 | PHASE3 |
| NCT04646187 | University Medical Center Groningen|European Crohn?s and Colitis Organisation|Bühlmann Laboratories AG | Inflammatory Bowel Diseases|Crohn Disease|Colitis, Ulcerative | 2021-03-11 | PHASE4 |
| NCT01114880 | Abbott | Ankylosing Spondylitis | 2010-01 | PHASE3 |
| NCT02035800 | Université de Sherbrooke|AbbVie | RheumatoId Arthritis | 2013-05 | PHASE4 |
| NCT06941376 | University of Pennsylvania | Relapsing Polychondritis | 2025-08-01 | PHASE2 |
| NCT02141997 | AbbVie | Rheumatoid Arthritis | 2014-07 | PHASE2 |
| NCT03254810 | Synermore Biologics Co., Ltd. | Arthritis, Rheumatoid | 2017-09-26 | PHASE1 |
| NCT03016260 | TcLand Expression S.A.|European Commission | RheumatoId Arthritis | 2016-12 | |
| NCT03983876 | Alvotech Swiss AG | Phase 1 | 2019-07-01 | PHASE1 |
| NCT05626348 | Qilu Hospital of Shandong University | Arthritis, Rheumatoid | 2021-12-22 | PHASE4 |
| NCT00195650 | Abbott | Rheumatoid Arthritis | 2000-07 | PHASE3 |
| NCT01265823 | AbbVie (prior sponsor, Abbott) | Psoriasis | 2010-10 | PHASE4 |
| NCT01136252 | Hospital Universitari Vall d´Hebron Research Institute | Age-Related Macular Degeneration|Choroidal Neovascularization | 2010-05 | PHASE2 |
| NCT00427921 | Abbott | Crohn´s Disease | 2007-01 | PHASE3 |
| NCT06996652 | Yale University|The Marcus Foundation|National Institute on Aging (NIA) | REM Sleep Behavior Disorder | 2026-05 | PHASE2 |
| NCT03412747 | UCB Biopharma SRL | Chronic Plaque Psoriasis|Moderate to Severe Plaque Psoriasis | 2018-01-26 | PHASE3 |
| NCT00291915 | Goupe d´Etudes et de Recherche Clinique En Rhumatologie | Rheumatoid Arthritis|Arthritis | 2004-05 | PHASE4 |
| NCT00550446 | Pfizer | Arthritis, Rheumatoid | 2007-09 | PHASE2 |
| NCT04089514 | Biogen | Arthritis, Rheumatoid (RA)|Axial Spondyloarthritis (axSpA)|Arthritis, Psoriatic (PsA)|Crohn´s Disease (CD)|Colitis, Ulcerative (UC) | 2019-06-30 | |
| NCT00085644 | Abbott | Ankylosing Spondylitis | 2004-01 | PHASE3 |
| NCT00385736 | Abbott | Ulcerative Colitis | 2006-11 | PHASE3 |
| NCT01231321 | Abbott | Rheumatoid Arthritis | 2007-12 | PHASE3 |
| NCT01866592 | University of Pennsylvania|AbbVie | Psoriasis|Cardiovascular Disease | 2013-04 | PHASE4 |
| NCT01138657 | AbbVie (prior sponsor, Abbott) | Uveitis | 2010-08 | PHASE3 |
| NCT02533375 | AbbVie | Generalized Pustular Psoriasis (GPP)|Adalimumab|Japanese | 2015-09-28 | PHASE3 |
| NCT07113834 | Benha University | Uveitis | 2023-09-01 | |
| NCT05928039 | University of Calgary|Alimentiv Inc. | Crohn Disease | 2023-10-25 | PHASE4 |
| NCT01644396 | AbbVie (prior sponsor, Abbott) | Moderate to Severe Plaque Psoriasis | 2012-05 | PHASE4 |
| NCT06833112 | The Affiliated Hospital Of Guizhou Medical University | Ankylosing Spondylitis | 2025-02 | PHASE4 |
| NCT02852694 | PIBD-Net|European Commission | Crohn´s Disease | 2017-02-28 | PHASE4 |
| NCT00870467 | Abbott|Eisai Co., Ltd. | Rheumatoid Arthritis | 2009-03 | PHASE3 |
| NCT02374021 | Brigham and Women´s Hospital|Columbia University | Arthritis, Rheumatoid | 2016-07 | PHASE4 |
| NCT00470509 | University Hospital, Geneva | Sciatica | 2005-05 | PHASE2 |
| NCT06180382 | Centre Hospitalier Universitaire de Saint Etienne|Takeda France | Crohn´s Disease | 2024-10-31 | PHASE4 |
| NCT03172325 | Cinnagen | Active Rheumatoid Arthritis | 2015-11-18 | PHASE3 |
| NCT07529925 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Severe Plaque Psoriasis in Chinese Children | 2026-05 | PHASE4 |
| NCT05153200 | Ottawa Hospital Research Institute|The Ottawa Hospital|University of Ottawa | Rheumatoid Arthritis | 2022-01 | PHASE4 |
| NCT00133315 | Hvidovre University Hospital | Spondylarthropathies|Ankylosing Spondylitis|Psoriatic Arthritis | 2004-09 | PHASE4 |
| NCT00235833 | Abbott|Abbott Japan Co.,Ltd|Eisai Co., Ltd. | Rheumatoid Arthritis | 2003-06 | PHASE2 |
| NCT01500278 | UCB Pharma SA|Parexel | Rheumatoid Arthritis | 2011-12 | PHASE4 |
| NCT01078571 | Abbott | Rheumatoid Arthritis | 2006-05 | |
| NCT02814175 | AbbVie | Psoriatic Arthritis | 2016-08-05 | PHASE4 |
| NCT01264770 | AstraZeneca | Rheumatoid Arthritis | 2011-01 | PHASE2 |
| NCT01899755 | GlaxoSmithKline | Psoriasis | 2013-07-10 | PHASE1 |
| NCT00216177 | Hvidovre University Hospital|University Hospital, Gentofte, Copenhagen | Rheumatoid Arthritis | 2005-09 | PHASE4 |
| NCT00445939 | Abbott|Abbott Japan Co.,Ltd|Eisai Co., Ltd. | Crohn´s Disease | 2007-02 | PHASE2|PHASE3 |
| NCT04551352 | Hoffmann-La Roche | Cutaneous Melanoma|Uveal Melanoma|Mucosal Melanoma | 2020-10-28 | PHASE1 |
| NCT03561649 | University Hospital, Grenoble|SINNOVIAL | Spondylitis, Ankylosing | 2018-06-14 | NA |
| NCT01752855 | AbbVie (prior sponsor, Abbott) | Rheumatoid Arthritis | 2012-12 | PHASE2 |
| NCT01502423 | AbbVie (prior sponsor, Abbott) | Rheumatoid Arthritis | 2012-01 | PHASE2 |
| NCT00597623 | Assistance Publique - H?pitaux de Paris|Abbott | Hand Osteoarthritis | 2008-01 | PHASE3 |
| NCT06640517 | Biocad | Plaque Psoriasis | 2024-08-08 | PHASE3 |
| NCT02207231 | Janssen Research & Development, LLC | Psoriasis | 2014-11-26 | PHASE3 |
| NCT02198651 | AbbVie | Rheumatoid Arthritis|Musculoskeletal and Connective Tissue Diseases | 2015-01-05 | PHASE4 |
| NCT05530122 | Tampere University Hospital | Ulcerative Colitis | 2009-01 | |
| NCT05291039 | Rehab Werida | Inflammatory Bowel Diseases | 2022-01-01 | NA |
| NCT03100253 | Mario Negri Institute for Pharmacological Research | Rheumatoid Arthritis | 2018-03-01 | PHASE4 |
| NCT05640245 | MoonLake Immunotherapeutics AG | Arthritis, Psoriatic | 2022-12-13 | PHASE2 |
| NCT04003922 | Assistance Publique Hopitaux De Marseille | Rasmussen Encephalitis | 2020-04-21 | |
| NCT03607903 | Centre for Human Drug Research, Netherlands|Leiden University Medical Center|Leiden Academic Center for Drug Research, the Netherlands | Pain|Injection Site | 2018-07-11 | PHASE1|PHASE2 |
| NCT02878161 | Fen Li | Rheumatoid Arthritis | 2016-01 | PHASE4 |
| NCT00055523 | Abbott | Crohn´s Disease | 2002-04 | PHASE2 |
| NCT00048542 | Abbott | Arthritis, Juvenile Idiopathic | 2002-09 | PHASE3 |
| NCT01174186 | Regionshospitalet Silkeborg|Abbott|Medtronic - MITG|Central Denmark Region | Spondyloarthritis|Enterocolitis | 2010-10 | PHASE4 |
| NCT01012570 | Gerhard Rogler | Crohn´s Disease | 2009-08 | |
| NCT00420927 | Abbott | Rheumatoid Arthritis | 2006-12 | PHASE4 |
| NCT00445432 | Abbott|Eisai Co., Ltd. | Crohn´s Disease | 2007-03 | PHASE2|PHASE3 |
| NCT01468207 | AbbVie (prior sponsor, Abbott) | Hidradenitis Suppurativa (HS) | 2011-11 | PHASE3 |
| NCT06258915 | Assistance Publique - H?pitaux de Paris | Non Infectious Uveitis | 2024-03-01 | PHASE3 |
| NCT06498089 | Shanghai Zhongshan Hospital | Takayasu Arteritis | 2024-06-28 | PHASE4 |
| NCT00274352 | Pariser, Robert J., M.D.|Abbott|Virginia Clinical Research, Inc. | Sarcoidosis | 2006-09 | PHASE2 |
| NCT00939003 | AbbVie (prior sponsor, Abbott) | Axial Spondyloarthritis | 2009-07 | PHASE3 |
| NCT03220841 | St Vincent´s Hospital Melbourne|Australasian Gastro Intestinal Research Foundation|AbbVie | Crohn Disease|Inflammatory Bowel Diseases|Stricture; Bowel | 2017-10-09 | PHASE4 |
| NCT00235859 | Abbott|Eisai Limited | Rheumatoid Arthritis | 2003-07 | PHASE3 |
| NCT02332590 | Sanofi|Regeneron Pharmaceuticals | Rheumatoid Arthritis | 2015-01-28 | PHASE3 |
| NCT00195676 | Abbott | Psoriasis | 2004-05 | PHASE3 |
| NCT04009668 | University of Michigan | FSGS|MCD|Focal Segmental Glomerulosclerosis|Minimal Change Disease | 2019-10-02 | PHASE2 |
| NCT02739828 | AbbVie | Hidradenitis Suppurativa | 2016-04-07 | |
| NCT00105300 | Abbott | Crohn´s Disease | 2004-10 | PHASE3 |
| NCT01550965 | AbbVie (prior sponsor, Abbott) | Ulcerative Colitis | 2012-05 | PHASE3 |
| NCT02332356 | Tokyo Medical and Dental University | Crohn Disease | 2014-09 | PHASE3 |
| NCT00649922 | Abbott | Rheumatoid Arthritis | 2003-10 | PHASE4 |
| NCT04909801 | Bristol-Myers Squibb | Rheumatoid Arthritis | 2021-09-15 | PHASE3 |
| NCT03261102 | waqqas.afif|AbbVie | Crohn Disease|Drug Monitoring|Inflammatory Bowel Diseases | 2017-01-17 | NA |
| NCT00538902 | Abbott | Rheumatoid Arthritis | 2007-08 | PHASE2|PHASE3 |
| NCT00448383 | Abbott | Rheumatoid Arthritis | 2002-09 | PHASE3 |
| NCT01562951 | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa|Abbott|TFS Trial Form Support | Crohn´s Disease|Mucosal Inflammation | 2012-10 | PHASE3 |
| NCT01468233 | AbbVie (prior sponsor, Abbott) | Hidradenitis Suppurativa (HS) | 2011-11 | PHASE3 |
| NCT01646073 | AbbVie (prior sponsor, Abbott) | Plaque Psoriasis | 2012-08 | PHASE3 |
| NCT02333383 | AbbVie | Ankylosing Spondylitis | 2014-12-31 | |
| NCT07352566 | University of California, San Francisco | Psoriasis|Atopic Dermatitis | 2026-01-01 | PHASE4 |
| NCT01561313 | AbbVie (prior sponsor, Abbott) | Rheumatoid Arthritis | 2012-03 | PHASE2 |
| NCT06269185 | Vastra Gotaland Region | Ulcerative Colitis|Inflammatory Bowel Diseases | 2024-03-06 | |
| NCT07061574 | City of Hope Medical Center|Jaeb Center for Health Research | Type 1 Diabetes|New Onset | 2026-03-10 | PHASE1|PHASE2 |
| NCT01029613 | Glostrup University Hospital, Copenhagen | Rheumatoid Arthritis | 2009-12 | |
| NCT00647400 | Abbott|Abbott Japan Co.,Ltd|Eisai Co., Ltd. | Psoriasis | 2006-04 | PHASE2|PHASE3 |
| NCT03153319 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|McGill University Health Centre+Research Institute of the McGill University Health Centre | Mucopolysaccharidosis I|Mucopolysaccharidosis II|Mucopolysaccharidosis VI | 2017-06-05 | PHASE1|PHASE2 |
| NCT07268534 | Assistance Publique - H?pitaux de Paris | Folliculitis Decalvans (FD) | 2026-04-01 | PHASE2 |
| NCT01144156 | Rabin Medical Center|Abbott | Crohn´s Disease | | NA |
| NCT02097264 | Novo Nordisk A+S | Inflammation|Rheumatoid Arthritis | 2014-09 | PHASE2 |
| NCT04705844 | Alachua Government Services, Inc.|Pharm-Olam, LLC|Chemical, Biological, Radiological, and Nuclear Medical | Mild to Moderate COVID-19 | 2021-09 | PHASE3 |
| NCT05527444 | Qilu Hospital of Shandong University | Ankylosing Spondylitis | 2022-03-15 | PHASE4 |
| NCT03579823 | Alvotech Swiss AG | Healthy Volunteers | 2018-05-21 | PHASE1 |
| NCT00477893 | Glostrup University Hospital, Copenhagen|Abbott | Spondyloarthritis | 2006-02 | PHASE4 |
| NCT02132234 | Jagiellonian University|Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland | Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis|Hypertension | 2013-06 | PHASE4 |
| NCT03311464 | AbbVie | Pyoderma Gangrenosum | 2017-10-27 | PHASE3 |
| NCT05427942 | Celltrion HealthCare France | Rheumatoid Arthritis|Ankylosing Spondylarthritis|Axial Spondyloarthritis Without Radiographic Evidence of Ankylosing Spondylitis|Psoriatic Arthritis|Crohn Disease|Ulcerative Colitis | 2022-06-03 | |
| NCT00525902 | Oregon Health and Science University|University of Illinois at Chicago|The Cleveland Clinic | Uveitis | 2008-01 | PHASE2 |
| NCT02808975 | AbbVie | Hidradenitis Suppurativa (HS) | 2016-07-18 | PHASE4 |
| NCT02019472 | Janssen Research & Development, LLC|GlaxoSmithKline | Arthritis, Rheumatoid | 2014-04-04 | PHASE3 |
| NCT01716039 | Alimentiv Inc.|Abbott | Ulcerative Colitis | 2013-06 | PHASE2 |
| NCT03059849 | McMaster University | Crohn Disease|Ulcerative Colitis | 2018-02-01 | PHASE4 |
| NCT00972218 | University of Alberta|Abbott | Spondyloarthritis|Crohn´s Disease | 2009-07 | PHASE4 |
| NCT02015793 | AbbVie | Crohn´s Disease | 2013-12 | PHASE2 |
| NCT01722214 | Innovaderm Research Inc.|Abbott|Montreal Heart Institute | Psoriasis|Vascular Inflammation|Coronary Atherosclerosis | 2012-11 | PHASE4 |
| NCT00296894 | University Hospital, Ghent | Erosive Osteo-Arthritis | 2006-05 | PHASE2 |
| NCT02632175 | AbbVie | Ulcerative Colitis | 2015-11-26 | PHASE3 |
| NCT00660647 | University of Aarhus|Abbott|Meda Pharmaceuticals|Aarhus University Hospital | Arthritis, Rheumatoid | 2007-09 | PHASE3 |
| NCT02480153 | Pfizer | Rheumatoid Arthritis | 2015-06-25 | PHASE3 |
| NCT01197144 | Karolinska Institutet|Abbott|Swedish Foundation for Strategic Research|The Swedish Research Council | Arthritis, Rheumatoid|Pain|Fatigue | 2010-10 | NA |
| NCT02963402 | Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau | Arthritis,Rheumatoid | 2016-11-09 | |
| NCT00235820 | Abbott | Psoriasis | 2005-07 | PHASE3 |
| NCT05814627 | AbbVie | Rheumatoid Arthritis | 2023-06-15 | PHASE3 |
| NCT06333210 | Biocad | Axial Spondyloarthritis | 2023-12-25 | PHASE3 |
| NCT03505008 | Keio University|Eisai Co., Ltd. | Rheumatoid Arthritis | 2018-04-18 | PHASE4 |
| NCT00338650 | Abbott | Crohn´s Disease | 2006-06 | PHASE3 |
| NCT07510191 | Sixth Affiliated Hospital, Sun Yat-sen University | Crohn Disease (CD) | 2026-03-01 | PHASE4 |
| NCT05172817 | Institute for Developing Science and Health Initiatives, Bangladesh|Universal Medical College Hospital, Bangladesh|Green Life Center for Rheumatic Care & Research, Bangladesh|Incepta Pharmaceuticals Ltd, Bangladesh | Pharmacokinetics|Safety|Efficacy|Rheumatoid Arthritis | 2021-06-02 | PHASE2|PHASE3 |
| NCT00646191 | Abbott | Psoriasis | 2003-03 | PHASE2 |
| NCT02489760 | Chung Shan Medical University | Ankylosing Spondylitis | 2008-07 | PHASE4 |
| NCT06370156 | Egymedicalpedia | Plaque Psoriasis | 2024-06-01 | |
| NCT04224194 | Alvotech Swiss AG | RA | 2019-11-04 | PHASE3 |
| NCT04453137 | Alvotech Swiss AG | Plaque Psoriasis | 2020-06-30 | PHASE3 |
| NCT03849313 | Alvotech Swiss AG | Healthy Volunteers | 2019-03-20 | PHASE1 |
| NCT01088165 | Medical University of Vienna | Psoriasis|Cardiovascular Diseases|Diabetes Mellitus, Type 2 | 2010-05 | PHASE4 |
| NCT00348153 | Heidelberg University|Abbott | Uveitis | 2006-08 | PHASE2|PHASE3 |
| NCT01494857 | Clalit Health Services | Ulcerative Colitis | 2012-01 | PHASE3 |
| NCT01602302 | Medical University of Graz | Rheumatoid Arthritis | 2012-06 | PHASE4 |
| NCT02171429 | Hoffmann-La Roche | Ulcerative Colitis | 2014-11-14 | PHASE3 |
| NCT06257875 | AbbVie | Ulcerative Colitis | 2024-03-23 | PHASE2 |
| NCT00649545 | Abbott | Rheumatoid Arthritis | | |
| NCT02668640 | AbbVie | Rheumatoid Arthritis | 2016-05-01 | |
| NCT00646386 | Abbott | Arthritis|Psoriatic | 2003-03 | PHASE2 |
| NCT04300686 | Shanghai Zhongshan Hospital | Takayasu Arteritis|Tocilizumab|Adalimumab|Treatment | 2020-03-01 | PHASE4 |
| NCT00235105 | Charite University, Berlin, Germany|Abbott | Ankylosing Spondylitis | 2005-03 | PHASE2|PHASE3 |
| NCT04230213 | Pfizer | Rheumatoid Arthritis | 2020-01-13 | PHASE3 |
| NCT00235872 | Abbott|Abbott Japan Co.,Ltd|Eisai Co., Ltd. | Rheumatoid Arthritis | 2004-08 | PHASE3 |
| NCT01895764 | University Hospital, Tours | Ankylosing Spondylitis | 2013-03-20 | PHASE4 |
| NCT01320293 | University of North Carolina, Chapel Hill|AbbVie | Psoriasis | 2011-03 | NA |
| NCT03464136 | Janssen Scientific Affairs, LLC | Crohn Disease | 2018-03-29 | PHASE3 |
| NCT05884242 | Janssen Research & Development, LLC | Healthy | 2023-05-22 | PHASE1 |
| NCT02330380 | University Hospitals Cleveland Medical Center|National Psoriasis Foundation | Psoriasis|Inflammation | 2013-04 | |
| NCT00497614 | University Hospital, Tours | Rheumatoid Arthritis | 2006-05 | NA |
| NCT06242652 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Ankylosing Spondylitis | 2024-03-19 | PHASE2 |
| NCT00234936 | Abbott | Rheumatoid Arthritis | 2003-12 | PHASE3 |
| NCT01877668 | Pfizer | Psoriatic Arthritis | 2014-01-20 | PHASE3 |
| NCT00233558 | Abbott | Rheumatoid Arthritis | 2005-06 | PHASE4 |
| NCT02252809 | Brugmann University Hospital | Innate Immunity | 2008-11 | EARLY_PHASE1 |
| NCT03172377 | Radboud University Medical Center|Erasmus Medical Center | Crohn Disease in Remission|Crohn Disease | 2017-05-03 | PHASE4 |
| NCT02927353 | Meiji Seika Pharma Co., Ltd. | Healthy Volunteer | 2016-08 | PHASE1 |
| NCT01029847 | Rigshospitalet, Denmark | Spondyloarthritis | 2009-12 | PHASE4 |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT01695239 | Eli Lilly and Company | Psoriasis, Arthritic | 2012-12 | PHASE3 |
| NCT03151551 | Eli Lilly and Company | Psoriatic Arthritis | 2017-08-24 | PHASE4 |
| NCT03662919 | Biogen | Arthritis, Rheumatoid|Spondylitis, Ankylosing|Arthritis, Psoriatic|Crohn´s Disease|Colitis, Ulcerative | 2018-07-02 | |
| NCT03414502 | University of Nebraska | Rheumatoid Arthritis | 2007-12-10 | PHASE3 |
| NCT03043677 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Disease | 2016-04-01 | |
| NCT02714322 | Mylan Inc.|Mylan GmbH | Psoriasis|Arthritis, Psoriatic | 2015-06 | PHASE3 |
| NCT00573794 | AbbVie (prior sponsor, Abbott) | Ulcerative Colitis | 2007-11-28 | PHASE3 |
| NCT04725422 | Seattle Children´s Hospital|Boston Children´s Hospital, Boston, MA, USA|Hospital for Special Surgery, New York|Joseph M Sanzari Children´s Hospital, Hackensack University Medical Center, Hackensack, NJ, USA|Riley Children´s Hospital, Indianapolis, IN, USA|University of North Carolina, Chapel Hill, NC, USA|Royal Children´s Hospital|Hacettepe University|Bambino Gesù Children´s Hospital, Rome, Italy|University of British Columbia, Vancouver, BC, Canada|Meyer Children´s Hospital, Florence, Italy|Mansoura University|University of Utah, Salt Lake City, UT, USA|University of Iowa Carver College of Medicine, Iowa City, IA, USA|Ann & Robert H Lurie Children´s Hospital of Chicago|Palacky University Olomouc Institute of Molecular and Translational Medicine, Olomouc, Czechia|Alder Hey Children´s NHS Foundation Trust|University of Calgary | Chronic Nonbacterial Osteomyelitis|Chronic Recurrent Multifocal Osteomyelitis | 2018-08-01 | |
| NCT04255134 | St George´s, University of London | Rheumatoid Arthritis | 2020-09-07 | PHASE4 |
| NCT00808509 | AbbVie (prior sponsor, Abbott)|Pharma Consulting Group AB | Arthritis, Rheumatoid | 2009-01 | PHASE4 |
| NCT01251614 | AbbVie (prior sponsor, Abbott) | Plaque Psoriasis | 2010-12 | PHASE3 |
| NCT03955861 | Belfast Health and Social Care Trust|British Medical Association|Psoriasis and Psoriatic Arthritis Alliance|Queen´s University, Belfast | Psoriatic Arthritis|Psoriasis|Enthesitis | 2019-02-14 | |
| NCT03849404 | Alvotech Swiss AG | Plaque Psoriasis | 2019-02-20 | PHASE3 |
| NCT00814255 | NYU Langone Health|University of Michigan|The Cleveland Clinic|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Focal Segmental Glomerulosclerosis | 2008-12 | PHASE2 |
| NCT00963313 | Dr. FRANCISCO J. BLANCO-GARCIA | Psoriatic Arthritis | 2010-03 | |
| NCT00667355 | Abbott|Eisai Co., Ltd. | Ankylosing Spondylitis | 2008-02 | PHASE3 |
| NCT05105347 | Peking Union Medical College Hospital | Uveitis | 2021-11-10 | PHASE4 |
| NCT02092961 | AstraZeneca | Rheumatoid Arthritis | 2011-02 | PHASE2 |
| NCT00827996 | Florida Academic Dermatology Centers|Abbott | Hidradenitis Suppurativa | 2007-02 | PHASE2 |
| NCT01958827 | AbbVie | Crohn´s Disease | 2013-09 | PHASE3 |
| NCT01970488 | Amgen | Psoriasis | 2013-10-18 | PHASE3 |
| NCT01768858 | AbbVie|Raffeiner GmbH | Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Crohn?s Disease|Ulcerative Colitis|Plaque Psoriasis | 2013-02-05 | |
| NCT02056184 | University of Leeds|AbbVie|Theorem | Rheumatoid Arthritis|Targeted Ultrasound | 2013-12 | PHASE4 |
| NCT01808118 | AbbVie | Axial Spondyloarthritis | 2013-04-16 | PHASE3 |
| NCT04588818 | Sun Yat-sen University | Uveitis | 2020-02-01 | PHASE2 |
| NCT00929864 | Bristol-Myers Squibb | Rheumatoid Arthritis | 2009-10 | PHASE3 |
| NCT02492217 | Universidade Nova de Lisboa | Ankylosing Spondylitis | 2015-05 | PHASE4 |
| NCT01736189 | AbbVie (prior sponsor, Abbott) | Rheumatoid Arthritis | 2012-10-11 | |
| NCT04131504 | Children´s Hospital Medical Center, Cincinnati|The Leona M. and Harry B. Helmsley Charitable Trust | Crohn´s Disease|IBD | 2019-10-16 | |
| NCT01635764 | AbbVie (prior sponsor, Abbott) | Hidradenitis Suppurativa | 2012-04 | PHASE3 |
| NCT01162421 | AbbVie (prior sponsor, Abbott)|Mount Sinai Hospital, Canada | Rheumatoid Arthritis | 2010-09 | PHASE4 |
| NCT01510548 | Kuopio University Hospital | Disc Prolapse|Pain | 2007-03 | PHASE3 |
| NCT03217734 | Jeffrey J Crowley MD|AbbVie | Psoriasis | 2017-04-10 | PHASE2|PHASE3 |
| NCT01072058 | University of Sao Paulo | Arthritis, Rheumatoid|Spondylitis, Ankylosing | 2008-02 | PHASE4 |
| NCT01405326 | The Rheumatological Center of Helsinki|Abbott | Rheumatoid Arthritis | 2011-05 | PHASE4 |
| NCT03917303 | Maastricht University Medical Center|Maastricht University|ZonMw: The Netherlands Organisation for Health Research and Development | Crohn Disease|Inflammatory Bowel Diseases | 2019-12-23 | PHASE4 |
| NCT05299242 | University of Oxford|National Institute for Health Research, United Kingdom|180 Life Sciences | Frozen Shoulder | 2022-07-21 | PHASE2|PHASE3 |
| NCT00837434 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence|Rho Federal Systems Division, Inc. | Rheumatoid Arthritis | 2009-03 | PHASE4 |
| NCT01064856 | AbbVie (prior sponsor, Abbott) | Peripheral Spondyloarthritis | 2010-02 | PHASE3 |
| NCT00645905 | Abbott | Psoriasis | 2003-06 | PHASE2 |
| NCT00814866 | Université de Sherbrooke|Abbott | Rheumatoid Arthritis | 2008-09 | NA |
| NCT01556672 | Innovaderm Research Inc.|Abbott | Plaque Psoriasis|Crohn´s Disease | 2012-04 | PHASE4 |
| NCT00650026 | Abbott | Rheumatoid Arthritis | | |
| NCT05995691 | Amgen | Healthy Volunteers | 2014-11-24 | PHASE1 |
| NCT00603993 | Abbott|Abbott Japan Co.,Ltd|Eisai Co., Ltd. | Rheumatoid Arthritis | 2006-03 | PHASE3 |
| NCT04183608 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives|AbbVie | Ulcerative Colitis | 2020-01-14 | PHASE4 |
| NCT00574249 | Abbott | Chronic Plaque Psoriasis | 2007-11 | PHASE3 |
| NCT02833350 | Genentech, Inc. | Rheumatoid Arthritis | 2016-09-09 | PHASE2 |
| NCT01657513 | University Hospital, Gentofte, Copenhagen|The Michaelsen Foundation|Pfizer | Psoriasis | 2012-06 | NA |
| NCT06291948 | Laboratorios Richmond S.A.C.I.F.|FP Clinical Pharma S.R.L.|Custom Biologics | Pharmacokinetics|Safety Issues | 2022-08-01 | PHASE1 |
| NCT03885713 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2019-09-10 | PHASE4 |
| NCT00185562 | Stanford University | Osteoarthritis | 2005-06 | PHASE2 |
| NCT03927352 | Sinocelltech Ltd. | Psoriasis | 2019-09-05 | PHASE3 |
| NCT01163617 | AbbVie (prior sponsor, Abbott) | Rheumatoid Arthritis | 2010-05 | PHASE2 |
| NCT04527380 | Eli Lilly and Company | Juvenile Psoriatic Arthritis|Enthesitis Related Arthritis | 2021-04-13 | PHASE3 |
| NCT05164198 | Hanyang University Seoul Hospital|Linical Korea | Ankylosing Spondylitis|Axial Spondyloarthritis | 2022-01-15 | PHASE4 |
| NCT00645814 | Abbott | Psoriasis | 2003-03 | PHASE2 |
| NCT00514982 | National Institute of Allergy and Infectious Diseases (NIAID) | Hermanski-Pudlak Syndrome|Colitis|Cytokines|Lymphocytes|Drug Evaluation | 2007-08-07 | PHASE2 |
| NCT02499783 | AbbVie | Crohn´s Disease | 2015-08-17 | PHASE3 |
| NCT00049751 | Abbott | Rheumatoid Arthritis | 2002-09 | PHASE3 |
| NCT04404517 | Hospital Universitario La Paz | Inflammatory Bowel Diseases | 2019-10-01 | PHASE3 |
| NCT01764997 | Sanofi|Regeneron Pharmaceuticals | Rheumatoid Arthritis | 2013-04 | PHASE3 |
| NCT04115423 | Sungkyunkwan University|Ministry of Food and Drug Safety, Korea | Infection|Rheumatoid Arthritis | 2020-04-01 | |
| NCT01070303 | Abbott | Crohn´s Disease | 2002-08 | PHASE3 |
| NCT04514796 | Samsung Bioepis Co., Ltd. | Healthy | 2020-08-13 | PHASE1 |
| NCT00783510 | AbbVie | Juvenile Idiopathic Arthritis|JIA | 2008-07-11 | |
| NCT03357939 | Shanghai Henlius Biotech | Immune System Disorder | 2017-01-12 | PHASE1 |
| NCT04194827 | Reade Rheumatology Research Institute|ZonMw: The Netherlands Organisation for Health Research and Development|Sint Maartenskliniek | Rheumatoid Arthritis | 2020-03-01 | PHASE4 |
| NCT01237262 | University of Padova | Moderate to Severe Psoriasis.|Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern. | 2010-11 | PHASE4 |
| NCT02073526 | Oslo University Hospital | Inflammatory Bowel Disease|Crohn´s Disease|Ulcerative Colitis | 2013-05 | |
| NCT00595413 | EMD Serono|Merck KGaA, Darmstadt, Germany | Rheumatoid Arthritis | 2007-09 | PHASE2 |
| NCT00686374 | AbbVie (prior sponsor, Abbott) | Crohn´s Disease | 2008-05-01 | PHASE3 |
| NCT02207244 | Janssen Research & Development, LLC | Psoriasis | 2014-11-03 | PHASE3 |
| NCT01483599 | Janssen Inc. | Psoriasis | 2011-11-10 | PHASE2 |
| NCT03273192 | Cinnagen | Bioequivalence|Phase 1 | 2016-10-22 | PHASE1 |
| NCT02760407 | R-Pharm International, LLC|Quintiles, Inc.|OCT Clinical Trials | Rheumatoid Arthritis | 2016-06-06 | PHASE3 |
| NCT00853099 | AbbVie (prior sponsor, Abbott)|Eisai Co., Ltd. | Ulcerative Colitis | 2009-02 | PHASE3 |
| NCT02065557 | AbbVie | Ulcerative Colitis | 2014-10-13 | PHASE3 |
| NCT01970475 | Amgen | Arthritis, Rheumatoid | 2013-10 | PHASE3 |
| NCT04808739 | Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau | Psoriasis | 2020-06-01 | |
| NCT04798755 | Hospital San Carlos, Madrid | Uveitis | 2022-01-12 | PHASE3 |
| NCT02393378 | Takeda | Rheumatoid Arthritis | 2015-04-08 | PHASE2 |
| NCT03816397 | Nisha Acharya|Children´s Hospital of Philadelphia|Children´s Hospital Medical Center, Cincinnati|Children´s Mercy Hospital Kansas City|National Eye Institute (NEI)|Great Ormond Street Hospital for Children NHS Foundation Trust|University Hospitals Bristol and Weston NHS Foundation Trust|Alder Hey Children´s NHS Foundation Trust|Newcastle-upon-Tyne Hospitals NHS Trust|Sheffield Children´s NHS Foundation Trust|Cambridge University Hospitals NHS Foundation Trust|Royal Children´s Hospital|Norfolk and Norwich University Hospitals NHS Foundation Trust|Vanderbilt University Medical Center|University of California, Davis|University of Texas at Austin|University of Miami|University Hospitals, Leicester|University of Utah|Colorado Retina Associates|Manchester University NHS Foundation Trust | Uveitis|JIA | 2020-03-15 | PHASE4 |
| NCT06926478 | Massachusetts Eye and Ear Infirmary | Penetrating Keratoplasty|Multiple Graft Failure|Ocular Cicatricial Pemphigoid|Stevens-Johnson Syndrome | 2026-06-01 | PHASE1 |
| NCT00855608 | Rafic Hariri University Hospital|American University of Beirut Medical Center | Uveitis|Diabetic Retinopathy|Choroidal Neovascularization | 2009-03 | PHASE1 |
| NCT00796705 | National Institute of Allergy and Infectious Diseases (NIAID) | Rheumatoid Arthritis | 2008-11 | PHASE4 |
| NCT01000441 | University Hospital, Strasbourg, France | Rheumatoid Arthritis | 2009-12-23 | PHASE4 |
| NCT05683054 | University Hospital, Ghent|KU Leuven | Psoriasis | 2020-08-11 | PHASE4 |
| NCT02745080 | Novartis Pharmaceuticals | Psoriatic Arthritis | 2017-04-03 | PHASE3 |
| NCT05414201 | AbbVie | Non-infectious Intermediate Posterior- or Pan-uveitis | 2022-07-07 | PHASE4 |
| NCT05535738 | Wei-Che Ko | Skin Inflammation|Allergic Contact Dermatitis | 2022-11-15 | PHASE2|PHASE3 |
| NCT00305539 | Assistance Publique - H?pitaux de Paris|Abbott | Giant Cell Arteritis | 2006-05 | PHASE3 |
| NCT05502731 | Leiden University Medical Center|Galapagos NV | Rheumatoid Arthritis | 2022-10 | PHASE4 |
| NCT02196701 | AbbVie | Psoriasis | 2014-08-05 | PHASE3 |
| NCT00645892 | Abbott | Psoriasis | 2003-11 | PHASE2 |
| NCT00724672 | Merck Sharp & Dohme LLC | Rheumatoid Arthritis | 2008-09 | |
| NCT01243671 | AbbVie (prior sponsor, Abbott)|Eisai Co., Ltd. | Intestinal Beh?et´s Disease | 2010-10 | PHASE3 |
| NCT01124838 | AbbVie (prior sponsor, Abbott) | Uveitis | 2010-08 | PHASE3 |
| NCT01270087 | Skane University Hospital|Abbott|The Swedish Research Council|The Swedish Rheumatism Ass|Crafoord Foundation | Rheumatoid Arthritis | 2005-05 | PHASE4 |
| NCT02322008 | Regionshospitalet Viborg, Skive | Crohn´s Disease|Ulcerative Colitis|Inflammatory Bowel Disease | 2009-09 | |
| NCT04610476 | University of Erlangen-Nürnberg Medical School | Psoriatic Arthritis|Withdrawal|Reduction | 2020-10-19 | PHASE3 |
| NCT05889338 | Sohag University | Psoriasi | 2023-06 | NA |
| NCT02092467 | Pfizer | Arthritis, Rheumatoid | 2014-03-14 | PHASE4 |
| NCT05590416 | Tianjin Medical University | Vogt-Koyanagi-Harada Disease|Adalimumab | 2021-06-01 | |
| NCT06100744 | AbbVie | Juvenile Psoriatic Arthritis | 2024-07-08 | PHASE3 |
| NCT01295814 | ICStudy, LLC|Abbott | Interstitial Cystitis | 2011-03 | PHASE3 |
| NCT02557100 | Bristol-Myers Squibb | Rheumatoid Arthritis | 2015-11-19 | PHASE4 |
| NCT04988308 | Janssen Research & Development, LLC | Hidradenitis Suppurativa | 2021-10-12 | PHASE2 |
| NCT02185014 | AbbVie | Crohn´s Disease | 2014-08-12 | PHASE3 |
| NCT01712178 | AbbVie (prior sponsor, Abbott) | Rheumatoid Arthritis | 2012-06 | PHASE2 |
| NCT03895203 | UCB Biopharma SRL | Psoriatic Arthritis | 2019-04-03 | PHASE3 |
| NCT02764762 | Takeda | Crohn Disease | 2017-04-18 | PHASE4 |
| NCT00234884 | Abbott | Rheumatoid Arthritis | 2003-09 | |
| NCT07423533 | Changchun GeneScience Pharmaceutical Co., Ltd. | Rheumatoid Arthritis | 2026-02 | PHASE2 |
| NCT01270035 | Keio University|Saitama Medical University | Rheumatoid Arthritis | 2011-01 | PHASE4 |
| NCT02694523 | AbbVie|Boehringer Ingelheim | Psoriasis | 2016-03 | PHASE3 |
| NCT02893254 | Innovent Biologics (Suzhou) Co. Ltd. | AS | 2016-09-22 | PHASE3 |
| NCT02150473 | Heinrich-Heine University, Duesseldorf|Abbott | Rheumatoid Arthritis | 2014-10 | PHASE3 |
| NCT00690846 | Wake Forest University Health Sciences | Pyoderma Gangrenosum | 2007-07 | PHASE2 |
| NCT02148718 | AbbVie|Laboratorio Echevarne|Pivotal S.L. | Moderate to Severe Crohn´s Disease | 2014-06 | PHASE4 |
| NCT01710358 | Eli Lilly and Company | Rheumatoid Arthritis | 2012-10 | PHASE3 |
| NCT01119859 | Hoffmann-La Roche | Rheumatoid Arthritis | 2010-05 | PHASE4 |
| NCT00421642 | Mayo Clinic | Ulcerative Colitis | 2006-10 | PHASE1 |
| NCT00348283 | Abbott | Crohn´s Disease | 2006-08 | PHASE3 |
| NCT04643483 | UCB Biopharma SRL | Crohn´s Disease | 2021-06 | PHASE3 |
| NCT00195702 | Abbott | Rheumatoid Arthritis | 2000-02 | PHASE3 |
| NCT06310837 | Zhongshan Ophthalmic Center, Sun Yat-sen University|The Eye Hospital of Wenzhou Medical University|The First Affiliated Hospital of Soochow University|Shandong Eye Hospital|Shenzhen Eye Hospital | Uveitis | 2024-03-27 | NA |
| NCT02929251 | Assistance Publique - H?pitaux de Paris | Uveitis|Biotherapy | 2017-06-29 | PHASE2 |
| NCT02437253 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Mucopolysaccharidosis Type I|Mucopolysaccharidosis Type II|Mucopolysaccharidosis Type VI | 2015-05 | PHASE1|PHASE2 |
| NCT00736983 | Foundation for Liver Research | Crohn´s Disease With Perianal Fistulas | 2008-09 | PHASE3 |
| NCT01373151 | CSL Behring | Rheumatoid Arthritis | 2011-06 | PHASE2 |
| NCT00650390 | Abbott | Rheumatoid Arthritis | | |
| NCT03221621 | Erasmus Medical Center|Prothya Biosolutions | Hidradenitis Suppurativa | 2018-07-31 | PHASE4 |
| NCT03737708 | Astellas Pharma Korea, Inc. | Rheumatoid Arthritis (RA) | 2019-02-13 | PHASE4 |
| NCT00195715 | Abbott | Crohn´s Disease | 2004-09 | PHASE3 |
| NCT00427362 | Abbott | Psoriatic Arthritis | 2006-05 | PHASE3 |
| NCT01986127 | Sara Varea|Hospital Clinic of Barcelona | Crohn´s Disease | 2014-02-14 | PHASE3 |
| NCT01564823 | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa|Effice Servicios Para la Investigacion S.L. | Crohn?s Disease | 2012-06 | PHASE3 |
| NCT02113904 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Netherton Syndrome | 2014-01-27 | PHASE2 |
| NCT00646178 | Abbott | Arthritis|Psoriatic | 2003-06 | PHASE3 |
| NCT05073315 | Amgen | Plaque Psoriasis | 2021-10-04 | PHASE3 |
| NCT01021735 | University of Glasgow|Arthritis Research UK|NHS Lothian|NHS Grampian|NHS Tayside|NHS Borders|NHS Fife | Rheumatoid Arthritis | 2010-04 | PHASE4 |
| NCT04154852 | University of Leeds|Abbott | Oligoarthritis | 2011-06 | PHASE2 |
| NCT07495644 | Assiut University | Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | 2026-03-01 | |
| NCT06037811 | Tom Appleton|Canadian Research Group in Immuno-Oncology|Western University | Inflammatory Arthritis|Immune-related Adverse Event | 2024-04-15 | PHASE2 |
| NCT01225393 | Genentech, Inc. | Rheumatoid Arthritis | 2010-11 | PHASE2 |
| NCT00195819 | Abbott | Ankylosing Spondylitis | 2003-12 | PHASE3 |
| NCT04171414 | Celltrion|PPD Development, LP | Rheumatoid Arthritis | 2019-09-09 | PHASE3 |
| NCT00237887 | Abbott | Psoriasis | 2004-12 | PHASE3 |
| NCT00298272 | Biogen|Hoffmann-La Roche|Genentech, Inc. | Rheumatoid Arthritis | 2006-05 | PHASE2 |
| NCT07013838 | Chinese SLE Treatment And Research Group | Takayasu Arteritis (TAK) | 2025-06-15 | PHASE4 |
| NCT01610947 | University Hospital, Montpellier | Spondyloarthritis | 2012-05-14 | NA |
| NCT00690573 | Abbott|Eisai Co., Ltd. | Juvenile Rheumatoid Arthritis | 2008-05 | PHASE3 |
| NCT01338740 | University Hospital, Ghent|Abbott | Crohn´s Disease | 2011-04 | |
| NCT03619876 | Columbia University|Bristol-Myers Squibb | Rheumatoid Arthritis|Myocardial Inflammation | 2019-07-10 | PHASE4 |
| NCT05090124 | NHS Greater Glasgow and Clyde|University of Glasgow | Rheumatoid Arthritis | 2022-11-04 | NA |
| NCT07348588 | Centro de Pesquisa Rubens Siqueira | Retinitis Pigmentosa (RP)|Extensive Macular Atrophy With Pseudodrusen (EMAP) | 2024-03-01 | PHASE1|PHASE2 |
| NCT01387815 | AbbVie (prior sponsor, Abbott)|Cato Research|JSS Medical Research Inc. | Psoriasis | 2011-08-16 | |
| NCT01185288 | AbbVie (prior sponsor, Abbott) | Rheumatoid Arthritis | 2010-09 | PHASE4 |
| NCT01971970 | Erasmus Medical Center|Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases | 2013-10 | |
| NCT00234845 | Abbott | Rheumatoid Arthritis | 2003-03 | PHASE3 |
| NCT06045754 | Takeda | Crohn´s Disease | 2024-04-18 | PHASE4 |
| NCT03316781 | Shanghai Henlius Biotech | Plaque Psoriasis | 2017-10-27 | PHASE3 |
| NCT01185301 | AbbVie (prior sponsor, Abbott) | Early Rheumatoid Arthritis | 2010-10 | PHASE3 |
| NCT06600009 | Novartis | Psoriatic Arthritis | 2022-10-17 | |
| NCT02840175 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Juvenile Idiopathic Arthritis | 2017-05-18 | PHASE3 |
| NCT00735787 | Abbott | Psoriasis | 2008-08 | PHASE4 |
| NCT02897115 | AbbVie|IST GmbH, Germany|Hannover Medical School|Improvement by Movement GmbH, Germany | Axial Spondyloarthritis | 2016-09-12 | PHASE4 |
| NCT02696785 | Eli Lilly and Company | Spondyloarthritis | 2016-05-02 | PHASE3 |
| NCT02706704 | American University of Beirut Medical Center | Uveitis|Non-Infectious Uveitis | 2016-02 | PHASE2 |
| NCT00918255 | Abbott | Hidradenitis Suppurativa | 2009-04 | PHASE2 |
| NCT05590455 | ANRS, Emerging Infectious Diseases | Tuberculous Meningitis|HIV I Infection | 2023-04-11 | PHASE2 |
| NCT01235689 | AbbVie (prior sponsor, Abbott) | Crohn´s Disease | 2011-02-11 | PHASE3 |
| NCT01465438 | Glostrup University Hospital, Copenhagen|University Hospital, Gentofte, Copenhagen|Copenhagen University Hospital at Herlev|Copenhagen University Hospital, Hvidovre | Psoriatic Arthritis | 2006-11 | PHASE4 |
| NCT00647491 | Abbott|Eisai Limited | Rheumatoid Arthritis | 2004-02 | PHASE2|PHASE3 |
| NCT00408629 | Abbott | Ulcerative Colitis | 2006-11 | PHASE3 |
| NCT00650156 | AbbVie | Rheumatoid Arthritis | 2007-06 | PHASE1 |
| NCT05503875 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Immunoclassification|Psoriasis | 2023-01-01 | NA |
| NCT01592292 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-11 | |
| NCT06527534 | Universita di Verona | Rheumatoid Arthritis | 2024-07-15 | PHASE4 |
| NCT01629628 | Tel-Aviv Sourasky Medical Center|Abbott | Crohn Disease | 2012-07 | PHASE3 |
| NCT01295151 | Julia Brown | Rheumatoid Arthritis | 2011-08 | PHASE4 |
| NCT01283971 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-05 | PHASE4 |
| NCT03180957 | University of Oxford|Department of Health, United Kingdom|Wellcome Trust|180 Therapeutics LP | Dupuytren´s Disease | 2016-03-02 | PHASE2 |
| NCT01181570 | Innovaderm Research Inc.|Abbott | Psoriasis|Sleep Apnea, Obstructive | 2010-09 | PHASE4 |